Guide

Does Insurance Cover Ozempic, Wegovy, Zepbound & Mounjaro? (2026 Guide + Appeal Letter)

Whether your plan pays for a GLP-1 comes down to one question first: is it prescribed for type 2 diabetes or for weight loss? Diabetes coverage is close to standard. Weight-loss coverage depends on your employer, your plan's pharmacy benefit manager and, for Medicare, a new $50 program with strict BMI rules. Here's how each type of coverage works in 2026, what prior authorization asks for, and how to appeal a denial, with a letter builder to get you started.

Medically reviewed Medically reviewed by Sabrina Griswold, Pharm.D. — NPI 1821451063 · Last updated 2026-11-10

Medical disclaimer Coverage rules change often and differ by plan, even within the same insurer. This guide summarizes published rules as of November 2026; it isn't legal advice or a coverage decision. Check your own plan's formulary and benefits, or call us and we'll check for you.
Quick answer
  • For type 2 diabetes (Ozempic, Mounjaro): covered by almost every plan, including Medicare Part D and Connecticut Medicaid, usually with prior authorization.
  • For weight loss (Wegovy, Zepbound, Foundayo): commercial plans cover it only if your employer or plan includes weight-loss drugs. Medicare covers it for $50 a month through the GLP-1 Bridge (July 2026–December 2027) if you meet BMI rules. Connecticut HUSKY doesn't cover weight loss.
  • Denied? You usually have 180 days to appeal, and then an independent external review. Use the letter builder below to start.
$50Monthly cost on Medicare's GLP-1 Bridge for eligible weight-loss patients (CMS)
180 daysTo file an internal appeal after a denial, most job-based and Marketplace plans
45 daysDeadline for an independent external review decision; 72 hours if urgent

Coverage at a glance, by reason and plan type

The reason on your prescription matters more than the brand. Each GLP-1 is approved for specific uses, and plans cover those uses under different rules:

Prescribed forJob-based or Marketplace planMedicareHUSKY (CT Medicaid)TRICARE
Type 2 diabetes
Ozempic, Mounjaro, Ozempic tablets, Rybelsus
Usually covered, with prior authorizationPart D covers; $2,100 yearly cap in 2026Covered, usually with prior authorizationCovered
Weight loss
Wegovy, Zepbound, Foundayo
Only if your plan includes weight-loss drugs$50 Bridge, if BMI rules are metNot covered since mid-2025Prime and Select with prior authorization; not TRICARE For Life
Sleep apnea
Zepbound
Depends on plan; a separate approved usePart D can coverAsk us to checkAsk us to check
Heart-risk reduction
Wegovy, with heart disease
Depends on plan; a separate approved usePart D can coverAsk us to checkAsk us to check

Sources: CMS Medicare GLP-1 Bridge pages; CMS 2026 Part D instructions; CT Mirror on HUSKY; MOAA on TRICARE For Life. Individual plans vary.

For commercial plans, the insurer usually isn't the one deciding whether weight-loss drugs are covered. Your employer chooses whether to include them.

Aetna, Cigna, UnitedHealthcare, Blue Cross, TRICARE

Two layers decide your coverage: whether your plan includes the drug's use at all (for weight loss, usually your employer's choice) and which GLP-1 the pharmacy benefit manager prefers. Here's what's known about each:

CVS Health · CVS Caremark

Aetna

Weight loss
Only on plans that include it. Many Aetna plans use the CVS Caremark formulary, which preferred Wegovy from July 2025 and added Zepbound back as a preferred option on October 1, 2026 (plus Foundayo from June 1, 2026).
Diabetes
Ozempic and Mounjaro generally covered with prior authorization
Cigna Group · Express Scripts

Cigna

Weight loss
Only on plans that include it; Express Scripts sets the preferred drug and prior authorization criteria
Diabetes
Commonly covered with prior authorization
UnitedHealth Group · Optum Rx

UnitedHealthcare

Weight loss
Only on plans that include it; Optum Rx sets the preferred drug and criteria
Diabetes
Commonly covered with prior authorization
Independent companies by state

Blue Cross Blue Shield

In Connecticut
The Blue plan is Anthem; rules vary by employer and by individual plan
Diabetes
Generally covered with prior authorization
Military

TRICARE

Prime and Select
Wegovy and Zepbound covered for weight loss with an approved prior authorization
TRICARE For Life
Weight-loss coverage ended August 31, 2025; diabetes still covered. Medicare's $50 Bridge may be an option with Part D.
Not in Connecticut

Kaiser Permanente

Coverage
Kaiser doesn't operate in Connecticut. Where it does, weight-loss coverage depends on the region and the plan.
Diabetes
Typically covered on its formulary

The fastest way to know for sure: call the member services number on your card and ask three questions:

  1. "Does my plan cover weight-loss medications, or exclude them?"If excluded, an appeal rarely works. Your employer's benefits team is the place to ask for a change.
  2. "Is [drug] on my formulary, and is it the preferred one?"If another GLP-1 is preferred, you may have to try it first (step therapy).
  3. "What are the prior authorization criteria?"Write down the BMI cutoff, required conditions and any required diet program, and give them to your prescriber.

Medicare: Part D and the $50 GLP-1 Bridge

Part D covers GLP-1s for their approved medical uses: Ozempic and Mounjaro for type 2 diabetes, Wegovy for heart-risk reduction or MASH, and Zepbound for sleep apnea. In 2026 your out-of-pocket drug costs are capped at $2,100 for the year.

The Medicare GLP-1 Bridge (July 1, 2026 to December 31, 2027) covers GLP-1s for weight loss alone, which Part D was never allowed to do. It covers Wegovy (pen or pill), the Zepbound KwikPen and Foundayo. Eligibility, from CMS:

BMI when you started the GLP-1Plus at least one of these
35 or higherNo other condition needed
30 or higherHeart failure with preserved ejection fraction · uncontrolled high blood pressure (above 140/90 despite two blood pressure medicines) · chronic kidney disease stage 3a or higher
27 or higherPrediabetes · a previous heart attack · a previous stroke · symptomatic peripheral artery disease

What prior authorization asks for

Prior authorization (PA) is your plan's check that the drug fits its criteria before it pays. Your prescriber submits it; the pharmacy usually finds out it's needed when the claim is rejected. Plans commonly ask for:

For weight loss

  • BMI and weight on the date treatment started, from a clinic visit
  • Weight-related conditions: high blood pressure, prediabetes or diabetes, high cholesterol, sleep apnea, heart disease
  • A diet, exercise or behavioral program you've followed, often for several months
  • For renewals: weight lost since starting, usually as a percentage

For type 2 diabetes

  • A type 2 diabetes diagnosis code
  • Recent A1c
  • Metformin tried first, or a reason you can't take it
  • That you're not also taking another GLP-1
Why approvals stall

The most common gap is paperwork, not eligibility: a BMI that wasn't recorded at the start, no documented diet program, or the wrong diagnosis code. Ask your prescriber's office to include all of it on the first submission. When a PA is approved, ask when it expires: most approvals have an end date and need renewing, often with proof of results.

If you're denied: how to appeal

Day 0

Denial letter arrives. Read the reason: missing information, step therapy, a different preferred drug, or a plan exclusion.

Within 180 days

File an internal appeal with your plan, with a letter from you and, ideally, a letter of medical necessity from your prescriber.

Within 30 days

Plan decides for a drug you haven't received yet (faster if urgent).

Within 4 months

Request an external review by an independent reviewer if the plan still says no. Standard decision within 45 days, expedited within 72 hours.

Timelines for job-based and Marketplace plans, from HealthCare.gov. Medicare Part D and Medicaid have their own appeal steps; the deadline is printed on your denial notice.

GLP-1 appeal letter builder

Fill in what you know and get a draft appeal letter to print or copy. Nothing you type leaves this page. Give the draft to your prescriber: a letter of medical necessity signed by them carries the most weight.

If it's simply not covered

Let us check your coverage first

Call Arrow Pharmacy at (860) 522-9289 before your prescriber sends the prescription. We'll run a test claim, tell you whether prior authorization is needed and which GLP-1 your plan prefers, and apply the manufacturer savings card if you qualify. Already filling elsewhere? We can transfer it.

Frequently asked questions

Does insurance cover Ozempic?

For type 2 diabetes, almost always, usually with prior authorization and sometimes after a trial of metformin. That includes commercial plans, Medicare Part D and Connecticut Medicaid (HUSKY). For weight loss without diabetes, Ozempic isn't approved, so plans rarely cover it; the approved semaglutide for weight loss is Wegovy.

Does Medicare cover Zepbound or Wegovy for weight loss?

Through the Medicare GLP-1 Bridge, yes, from July 1, 2026 to December 31, 2027: Wegovy (pen or pill), the Zepbound KwikPen and Foundayo cost $50 a month if you qualify. You need a BMI of 35 or more, or 30 or more with heart failure with preserved ejection fraction, uncontrolled high blood pressure or stage 3a+ kidney disease, or 27 or more with prediabetes, a past heart attack or stroke, or symptomatic peripheral artery disease. Your prescriber requests approval from CMS.

Does Medicare cover Ozempic or Mounjaro?

Yes, for type 2 diabetes. Medicare Part D plans cover them, usually with prior authorization, and in 2026 your yearly out-of-pocket drug costs are capped at $2,100. Manufacturer $25 savings cards can't be used with Medicare.

Does Medicaid cover Ozempic or Wegovy?

Medicaid covers GLP-1s for type 2 diabetes in every state, usually with prior authorization. Coverage for weight loss is each state's choice. Connecticut's HUSKY stopped covering GLP-1s prescribed only for weight loss in mid-2025 because of cost; it still covers them for type 2 diabetes and certain other approved uses.

Does Aetna cover Zepbound or Wegovy?

It depends on whether your employer's plan includes weight-loss drugs. Aetna is owned by CVS Health, and many Aetna plans use CVS Caremark's formulary, which made Wegovy the preferred weight-loss GLP-1 in July 2025 and added Zepbound back as a preferred option on October 1, 2026. Call the number on your card to confirm your plan's formulary and prior authorization rules.

Does Cigna or UnitedHealthcare cover Zepbound and Wegovy?

Both cover them only on plans that include weight-loss medication, which is usually the employer's decision. Cigna plans typically use Express Scripts and UnitedHealthcare plans Optum Rx as the pharmacy benefit manager, and each sets which GLP-1 is preferred and what prior authorization requires. For type 2 diabetes, Ozempic and Mounjaro are commonly covered with prior authorization.

Does Blue Cross Blue Shield cover Ozempic, Wegovy or Zepbound?

Blue Cross Blue Shield is a network of independent companies, so the answer varies by state and plan. In Connecticut the Blue plan is Anthem. Diabetes use is generally covered with prior authorization; weight-loss coverage depends on whether your employer or individual plan includes it.

Does TRICARE cover Wegovy and Zepbound?

TRICARE Prime and Select cover weight-loss GLP-1s such as Wegovy and Zepbound with an approved prior authorization. TRICARE For Life, the plan for Medicare-eligible retirees, stopped covering GLP-1s for weight loss on August 31, 2025; GLP-1s for type 2 diabetes are still covered. TRICARE For Life members may qualify for Medicare's $50 GLP-1 Bridge if they have Part D.

How do I get Zepbound covered by insurance?

First confirm your plan covers weight-loss drugs at all. Then have your prescriber submit prior authorization with your BMI at the start of treatment, your weight-related conditions, and any diet and exercise program or medicines you've tried. If your plan prefers Wegovy, it may require a trial of Wegovy first. Zepbound for obstructive sleep apnea is a separate approved use that some plans, and Medicare Part D, cover even when weight loss isn't covered.

What if my GLP-1 prior authorization is denied?

You can appeal. For most job-based and Marketplace plans you have 180 days to file an internal appeal, and the plan must decide within 30 days for a drug you haven't received yet. If it still says no, you can ask for an independent external review within 4 months; standard reviews are decided within 45 days, urgent ones within 72 hours. A letter from your prescriber explaining medical necessity is the strongest support.

Will insurance cover Ozempic for prediabetes?

Rarely. No GLP-1 is FDA-approved for prediabetes alone, and plans almost always limit Ozempic to type 2 diabetes. Prediabetes can help you qualify for a weight-loss GLP-1 instead: Medicare's Bridge accepts a BMI of 27 or more with prediabetes, and many commercial plans count it as a weight-related condition.

Call (860) 522-9289 Refill online